Skip to main content
MRVI logo
MRVI
(NASDAQ)
Maravai LifeSciences Holdings, Inc.
$6.12-- (--)
Loading... - Market loading

Maravai LifeSciences Holdings, Inc. (MRVI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Maravai LifeSciences Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
Medium Confidence:1 Buy/Sell

Average Price Target

$5.67
7.35% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MRVI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edmund Ingham
Forbes
BuyInitiates Coverage
-
Daniel Arias
Stifel Nicolaus
BuyMaintains
$4.00 $6.00
Subbu Nambi
Guggenheim
HoldMaintains
-
Matt Hewitt
Craig-Hallum
BuyReiterates
$5.00
Matt Larew
William Blair
HoldMaintains
-
Justin Bowers
Deutsche Bank
BuyMaintains
$4.50 $6.00

Frequently Asked Questions

What is the analyst consensus rating for MRVI?

The analyst consensus rating for MRVI is "Buy" based on 6 analyst recommendations.

What is the average price target for MRVI?

The average 12-month price target for MRVI is $5.67, representing a downside of 7.4% from the current price of $6.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.